What are the possible causes of severe leukopenia with neutropenia and eosinopenia?

Severe Leukopenia with Neutropenia and Eosinopenia: Causes

These laboratory values (WBC 1.9, absolute neutrophils 635, absolute eosinophils 10) indicate severe leukopenia with neutropenia and eosinopenia, most commonly caused by drug-induced bone marrow suppression, hematologic malignancies (particularly myelodysplastic syndromes or acute leukemia), or severe acute infection.

Primary Diagnostic Considerations

Drug-Induced Myelosuppression

The most common reversible cause of this pattern is chemotherapy or immunosuppressive medications 1, 2. Specific agents to investigate include:

• Azathioprine (causes marrow depression with neutropenia requiring regular monitoring) 2
• Hydroxyurea (can cause absolute neutrophil count <1.0×10⁹/L) 3
• Chemotherapy agents for cancer treatment 1

Critical action: Obtain detailed medication history including recent chemotherapy, immunosuppressants, or other myelosuppressive drugs.

Hematologic Malignancies

With an absolute neutrophil count of 635/mcL (0.635×10⁹/L), myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) must be excluded 4, 5, 6. The combination of pancytopenia (low WBC, neutropenia, and eosinopenia) suggests:

• MDS with marrow failure - particularly myelodysplastic-predominant (MD) phenotype 3
• Acute leukemia with marrow replacement 7
• Bone marrow infiltration by malignancy 5

Required workup:

• Bone marrow aspiration and biopsy with cytogenetics 5
• Peripheral blood smear for dysplasia and blast count 5
• Flow cytometry for CD34+ cells 5

Severe Acute Infection

Eosinopenia specifically suggests acute bacterial infection 8. The mechanism involves chemotactic factors of acute inflammation (C5a, N-formyl-methionyl-leucyl-phenylalanine) causing rapid disappearance of circulating eosinophils within minutes, with prolonged eosinopenia lasting hours 8. Severe infections can cause:

• Neutropenia from overwhelming sepsis with bone marrow suppression 1, 9
• Increased peripheral utilization exceeding production 9
• Tuberculosis (particularly severe pulmonary TB can cause leukopenia with neutropenia and lymphopenia) 10

Risk Stratification

Immediate Infection Risk

With absolute neutrophil count <750/mm³, the patient is at high risk for severe bacterial infection 1. Risk factors include:

• Infection risk greatest when neutrophil count <100/mcL (10-20% develop bloodstream infection) 1
• At 635/mcL, moderate-to-high infection risk exists 1
• Fever in this setting constitutes a medical emergency requiring immediate broad-spectrum antibiotics 11, 12

Duration and Tempo

• Acute onset (days to weeks): suggests drug toxicity, acute infection, or acute leukemia
• Chronic/stable (>6 months): more consistent with MDS, though only 2 months needed if dysplasia or specific cytogenetics present 5

Diagnostic Algorithm

Step 1: Immediate Assessment

• Check for fever (>38°C) - if present, initiate empirical broad-spectrum antibiotics immediately (piperacillin-tazobactam, carbapenem, or antipseudomonal cephalosporin) 1, 11
• Review ALL medications for myelosuppressive agents
• Assess for bleeding risk (check platelet count)

Step 2: Exclude Reversible Causes

• Vitamin B12 and folate levels 5
• HIV screening if clinically indicated 5
• Serum erythropoietin level 3, 5
• Thyroid function (if on interferon-based therapy) 13

Step 3: Bone Marrow Evaluation (unless obvious drug cause)

• Aspiration with Prussian blue stain for iron 5
• Biopsy for cellularity, fibrosis, dysplasia 5
• Cytogenetics (essential for MDS diagnosis and prognosis) 5
• Flow cytometry 5

Step 4: Specific Conditions to Consider

• TPMT deficiency if on azathioprine (1 in 300 people homozygous for low-activity allele) 2
• Hypersplenism causing sequestration 2
• Autoimmune neutropenia (consider in younger patients with hypoplastic marrow) 7
• Congenital disorders (rare: severe congenital neutropenia, myelokathexis) 14, 15

Critical Pitfalls to Avoid

1. Do not delay antibiotics if fever present - neutropenic fever has 50-60% infection rate, with mortality risk from delayed treatment 1

2. Do not assume drug-induced without bone marrow evaluation - MDS and leukemia can present identically and require different management 4, 5

3. Do not use G-CSF empirically without diagnosis - contraindicated in some conditions (e.g., may worsen MDS with high blast count) 16

4. Eosinopenia is not benign - it specifically indicates acute inflammatory process or infection requiring investigation 8

5. Monitor closely if continuing myelosuppressive drugs - weekly CBC for first 4 weeks, then 1-3 monthly 2

Management Principles Pending Diagnosis

• Supportive care: Avoid prophylactic platelet transfusions unless severe thrombocytopenia with bleeding 6, 16
• Infection prophylaxis: Broad-spectrum antibiotics only if febrile; do not use prophylactic antibiotics for neutropenia alone 6, 16
• Growth factors: Consider G-CSF only for febrile severe neutropenia, NOT routinely 3, 6
• Transfusion threshold: Maintain hemoglobin ≥8 g/dL (≥9-10 g/dL if comorbidities) 6

The combination of severe leukopenia, neutropenia, and eosinopenia requires urgent evaluation to distinguish between reversible drug toxicity, life-threatening infection, and underlying hematologic malignancy - each demands fundamentally different management approaches.